FDA’s ASCA Program Accelerates Medical Device Approvals by Standardizing Biocompatibility and Electrical Safety Testing

September 6, 2026

Element USA

Overview

The U.S. FDA’s Accreditation Scheme for Conformity Assessment (ASCA) program significantly accelerates medical device approval processes by allowing manufacturers to submit standardized test data from accredited labs. Covering critical areas like ISO 10993-series biocompatibility and IEC 60601-1-family electrical safety, essential performance, and EMC testing, ASCA reduces FDA review burden and time-to-market. This streamlines regulatory compliance and fosters faster patient access to innovative medical technologies.

In Depth

Key Findings

The U.S. Food and Drug Administration’s (FDA) Accreditation Scheme for Conformity Assessment (ASCA) program is serving as a pivotal framework to dramatically accelerate the approval process for medical devices. This program enables manufacturers to submit standardized test data from accredited testing laboratories, thereby alleviating the FDA’s review burden and facilitating more efficient market entry for innovative products.

Technical & Regulatory Details

Streamlined Approval Process: The ASCA program shortens review times for pre-market submissions by verifying that test results issued by ASCA-accredited laboratories conform to FDA standards. This allows manufacturers to optimize their product development cycles and deliver innovative medical devices to patients more quickly.
Key Testing Areas Covered:
- Biocompatibility Testing: Based on the ISO 10993 series (e.g., ISO 10993-1 for Biological evaluation and testing), this assesses how medical device materials interact with biological systems. It includes parameters such as cytotoxicity, sensitization, irritation, and hemolysis, ensuring patient safety.
- Electrical Safety and Performance Testing: Based on the IEC 60601-1 family (General requirements for basic safety and essential performance of medical electrical equipment), this evaluates the safety, essential performance, and electromagnetic compatibility (EMC) of medical electrical devices. This reduces the risk of device malfunction or harm to patients.
Standardized Data Submission: ASCA is designed to standardize the format and content of test results, allowing the FDA to review data more efficiently, which enhances data quality and consistency.

Background & Context

While stringent medical device approval processes are necessary to ensure patient safety, their complexity and protracted timelines have historically hindered the market introduction of new technologies. The ASCA program was introduced as part of the FDA’s strategy to resolve this bottleneck and accelerate medical innovation. Similar initiatives are also observed internationally, such as the European Medical Device Regulation (MDR).

Strategic Significance & Outlook

The proliferation of the ASCA program is expected to create an environment where medical device manufacturers can reduce time and costs associated with regulatory compliance, allowing them to focus more on research and development. This will enable high-functional, safe medical devices to reach the market more rapidly, contributing to expanded treatment options for patients and improved healthcare outcomes. Further expansion of the program could potentially cover additional testing areas in the future, establishing a more harmonized global standard.

Source: https://www.element.com/resources/white-papers/accelerating-fda-approval-with-the-asca-program

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.